Data / Form D filings / NeuroGeneces, Inc.
NeuroGeneces, Inc.: Form D filings
NeuroGeneces, Inc., a health care company in Santa Fe, NM, filed 4 Form D notices with the SEC between 2017 and 2026. The latest, on May 1, 2026, reports $425,000 sold of a $750,000 offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1012 Marquez Place #207A, Santa Fe, NM, 87505
- Phone
- (505) 780-8628
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1716111
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 1, 2026 | New notice | $750,000 | $425,000 | $325,000 | 13 | Nov 14, 2025 | sec.gov |
| Jan 28, 2019 | Amendment | $1,000,000 | $130,000 | $870,000 | 4 | Jan 1, 2018 | sec.gov |
| Apr 19, 2018 | New notice | Indefinite | $0 | 1 | Jan 15, 2018 | sec.gov | |
| Sep 11, 2017 | New notice | $1,000,000 | $0 | $1,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Karen Crow | Executive Officer, Director | |
| Barry Jason Worchel | Executive Officer, Director |
Every Form D from the week of Apr 27, 2026 · All recent filings in New Mexico · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what NeuroGeneces, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.